Corporate News     28-Jul-17
Astrazeneca Pharma India intimates of delay on termination of distribution arrangements for Menorem in India
Due to delay in divestment of AstraZeneca's global rights to Meronem
Astrazeneca Pharma India announced that it has received a letter from AstraZeneca UK to further extend the date of withdrawal of Meronem from 31 July 2017 to 31 August 2017, due to delay in the divestment of AstraZeneca's global rights to Meronem.

In August 2016, Astrazeneca had announced the termination of distribution arrangement by AstraZeneca UK for Meronem in India, pursuant to a global agreement by AstraZeneca PLC to sell the development and commercialisation rights to Pfizer Inc., of its late stage small molecule antibiotics business.

Further in December 2016, the validity period of the distribution agreement was extended till 31 July 2017, due to delay in the divestment of AstraZeneca's global rights to Meronem.

Previous News
  Astrazeneca Pharma India standalone net profit declines 45.03% in the June 2021 quarter
 ( Results - Announcements 09-Aug-21   15:05 )
  Astrazeneca Pharma India standalone net profit rises 60.84% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   07:33 )
  Astrazeneca Pharma India standalone net profit declines 38.28% in the March 2023 quarter
 ( Results - Announcements 31-May-23   07:43 )
  Astrazeneca Pharma India to declare Quarterly Result
 ( Corporate News - 02-Aug-21   17:55 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 08-Aug-19   10:11 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 10-Aug-20   16:20 )
  Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  Astrazeneca Pharma India standalone net profit declines 13.43% in the June 2020 quarter
 ( Results - Announcements 10-Aug-20   14:40 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 22-Jan-20   10:30 )
  AstraZeneca set to launch Osimertinib 40mg/80mg film coated tablets
 ( Corporate News - 10-Mar-21   16:33 )
  Board of Astrazeneca Pharma India decides to close API unit in Bangalore
 ( Corporate News - 03-Dec-15   20:35 )
Other Stories
  Ashoka Metcast to discuss results
  03-Oct-24   10:29
  Emerald Finance to declare Quarterly Result
  03-Oct-24   10:29
  Rhetan TMT schedules board meeting
  03-Oct-24   10:29
  Shrenik to table results
  03-Oct-24   10:29
  Universal Arts to declare Quarterly Result
  03-Oct-24   10:28
  Three M Paper Boards to conduct board meeting
  03-Oct-24   10:28
  Arkade Developers to declare Quarterly Result
  03-Oct-24   10:28
  Worth Investment & Trading Company announces board meeting date
  03-Oct-24   10:28
  Tech Mahindra to convene board meeting
  03-Oct-24   10:25
  Rane Brake Lining to declare Quarterly Result
  03-Oct-24   10:25
Back Top